Knockout of Silent Information Regulator 2 (SIRT2) Preserves Neurological Function after Experimental Stroke in Mice

[1]  C. Ayata,et al.  The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia , 2015, PloS one.

[2]  G. Trendelenburg Molecular Regulation of Cell Fate in Cerebral Ischemia: Role of the Inflammasome and Connected Pathways , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Yingxin Ma,et al.  SIRT2 mediates oxidative stress-induced apoptosis of differentiated PC12 cells , 2014, Neuroreport.

[4]  S. Hornemann,et al.  ASC has extracellular and prionoid activities that propagate inflammation , 2014, Nature Immunology.

[5]  M. Endres,et al.  Histone Acetylation and CREB Binding Protein Are Required for Neuronal Resistance against Ischemic Injury , 2014, PloS one.

[6]  D. Green,et al.  Is SIRT2 required for necroptosis? , 2014, Nature.

[7]  Ziying Wang,et al.  NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  S. Schuster,et al.  Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. , 2013, Nature chemical biology.

[9]  R. M. de Oliveira,et al.  The NAD‐dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation , 2013, The EMBO journal.

[10]  A. Planas,et al.  SIRT1 Regulation Modulates Stroke Outcome , 2013, Translational Stroke Research.

[11]  O. Hurtado,et al.  Silent Information Regulator 1 Protects the Brain Against Cerebral Ischemic Damage , 2013, Stroke.

[12]  L. O’Neill,et al.  How Metabolism Generates Signals during Innate Immunity and Inflammation* , 2013, The Journal of Biological Chemistry.

[13]  Xunbin Wei,et al.  Poly(ADP-ribose) polymerase mediates both cell death and ATP decreases in SIRT2 inhibitor AGK2-treated microglial BV2 cells , 2013, Neuroscience Letters.

[14]  J. Auwerx,et al.  Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. , 2013, Human molecular genetics.

[15]  M. Donath When metabolism met immunology , 2013, Nature Immunology.

[16]  S. Tenzer,et al.  A critical role for the cholesterol‐associated proteolipids PLP and M6B in myelination of the central nervous system , 2013, Glia.

[17]  S. Akira,et al.  Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome , 2013, Nature Immunology.

[18]  G. Donmez,et al.  SIRT1 and SIRT2: emerging targets in neurodegeneration , 2013, EMBO molecular medicine.

[19]  S. Hersch,et al.  The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models. , 2012, Cell reports.

[20]  L. Guarente,et al.  SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo , 2012, PloS one.

[21]  Caibin Sheng,et al.  NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases. , 2012, Current drug targets.

[22]  J. Auwerx,et al.  Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling , 2011, Proceedings of the National Academy of Sciences.

[23]  M. Perez-Pinzon,et al.  Pathways for Ischemic Cytoprotection: Role of Sirtuins in Caloric Restriction, Resveratrol, and Ischemic Preconditioning , 2011, Journal of Cerebral Blood Flow and Metabolism.

[24]  N. Hariharan,et al.  Silent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion , 2010, Circulation.

[25]  M. Endres,et al.  CD93/AA4.1: A Novel Regulator of Inflammation in Murine Focal Cerebral Ischemia , 2010, The Journal of Immunology.

[26]  U. Dirnagl,et al.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice , 2010, Journal of Neuroinflammation.

[27]  M. Endres,et al.  Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. , 2009, Biochimica et biophysica acta.

[28]  H. Hara,et al.  Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. , 2009, Biochemical and biophysical research communications.

[29]  C. Lascola,et al.  Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage , 2009, Stroke.

[30]  L. Guarente,et al.  Proteolipid Protein Is Required for Transport of Sirtuin 2 into CNS Myelin , 2007, The Journal of Neuroscience.

[31]  M. Tainsky,et al.  Microtubule Deacetylases, SirT2 and HDAC6, in the Nervous System , 2007, Neurochemical Research.

[32]  J. Garcìa,et al.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. , 1995, Stroke.

[33]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[34]  Edinburgh Research Explorer Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia , 2022 .